Laura Haar
Impact in
- Neurology top 2%
- Myasthenia Gravis and Thymoma
- Peripheral Neuropathies and Disorders
- Parkinson's Disease and Spinal Disorders
- Autoimmune Neurological Disorders and Treatments
-
- Antifungal resistance and susceptibility
Papers in
-
- Global trade and economics 4
-
- Myasthenia Gravis and Thymoma 5
Laura Haar
13 papers receiving 824 citations
Laura Haar's Hit Papers
Peers
Comparison fields: 5 of 77
- Neurology 658
- Infectious Diseases 138
- General Energy 6
- Immunology 89
- Genetics 34
Countries citing papers authored by Laura Haar
This map shows the geographic impact of Laura Haar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Haar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Haar more than expected).
Fields of papers citing papers by Laura Haar
This network shows the impact of papers produced by Laura Haar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Haar. The network helps show where Laura Haar may publish in the future.
Co-authors
The 1 scholars most cited alongside Laura Haar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study Hit paper breakdown → | 2017 | 622 |
| 2 | 2020 | 66 | |
| 3 | 2019 | 46 | |
| 4 | 2005 | 22 | |
| 5 | 2020 | 22 | |
| 6 | 2019 | 19 | |
| 7 | 2011 | 16 | |
| 8 | 2016 | 16 | |
| 9 | 2010 | 12 | |
| 10 | 2014 | 10 | |
| 11 | 2008 | 7 | |
| 12 | 2014 | 5 | |
| 13 | 2018 | 1 | |
| 14 | 2003 | 0 |
About Laura Haar
Laura Haar is a scholar working on General Economics, Econometrics and Finance, Neurology, Strategy and Management, General Energy and Accounting, having authored 14 papers that have together received 864 indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (5 papers), Global trade and economics (4 papers), Corporate Finance and Governance (3 papers), International Business and FDI (3 papers), Global Trade and Competitiveness (3 papers), Climate Change Policy and Economics (2 papers), Global Energy Security and Policy (2 papers) and Electric Power System Optimization (2 papers). The work is most often cited by research in Neurology (658 citations), Infectious Diseases (138 citations), General Energy (6 citations), Immunology (89 citations) and Genetics (34 citations). Laura Haar has collaborated with scholars based in United Kingdom, Romania and Saudi Arabia. Frequent co-authors include Cristinel Constantin. Their work appears in journals such as Energy Policy, The Lancet Neurology, Quality of Life Research, Europe Asia Studies and Journal of East-West Business.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.